X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs MERCK LTD - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH MERCK LTD STERLING BIOTECH/
MERCK LTD
 
P/E (TTM) x -1.8 26.8 - View Chart
P/BV x 0.1 3.0 2.3% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 STERLING BIOTECH   MERCK LTD
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
MERCK LTD
Dec-16
STERLING BIOTECH/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs111,060 1.0%   
Low Rs3623 0.5%   
Sales per share (Unadj.) Rs26.8632.4 4.2%  
Earnings per share (Unadj.) Rs-15.045.7 -32.7%  
Cash flow per share (Unadj.) Rs-5.562.3 -8.8%  
Dividends per share (Unadj.) Rs011.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs54.9388.8 14.1%  
Shares outstanding (eoy) m267.8716.60 1,613.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.3 19.5%   
Avg P/E ratio x-0.518.4 -2.5%  
P/CF ratio (eoy) x-1.313.5 -9.4%  
Price / Book Value ratio x0.12.2 5.9%  
Dividend payout %024.1 0.0%   
Avg Mkt Cap Rs m1,86213,969 13.3%   
No. of employees `0001.41.6 85.5%   
Total wages/salary Rs m5471,487 36.8%   
Avg. sales/employee Rs Th5,303.36,631.9 80.0%   
Avg. wages/employee Rs Th403.8939.2 43.0%   
Avg. net profit/employee Rs Th-2,959.0479.4 -617.2%   
INCOME DATA
Net Sales Rs m7,18110,498 68.4%  
Other income Rs m43242 17.6%   
Total revenues Rs m7,22310,741 67.3%   
Gross profit Rs m9471,135 83.4%  
Depreciation Rs m2,543276 923.1%   
Interest Rs m4,3770-   
Profit before tax Rs m-5,9311,102 -538.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924343 -560.5%   
Profit after tax Rs m-4,007759 -527.9%  
Gross profit margin %13.210.8 121.9%  
Effective tax rate %32.431.1 104.2%   
Net profit margin %-55.87.2 -771.8%  
BALANCE SHEET DATA
Current assets Rs m14,3356,410 223.7%   
Current liabilities Rs m49,8098,828 564.2%   
Net working cap to sales %-494.0-23.0 2,144.2%  
Current ratio x0.30.7 39.6%  
Inventory Days Days40358 699.3%  
Debtors Days Days17138 444.5%  
Net fixed assets Rs m55,4321,406 3,941.4%   
Share capital Rs m268166 161.4%   
"Free" reserves Rs m13,9356,286 221.7%   
Net worth Rs m14,7016,455 227.8%   
Long term debt Rs m9,4780-   
Total assets Rs m73,9888,828 838.1%  
Interest coverage x-0.4NM-  
Debt to equity ratio x0.60-  
Sales to assets ratio x0.11.2 8.2%   
Return on assets %0.58.6 5.8%  
Return on equity %-27.311.8 -231.8%  
Return on capital %-6.417.1 -37.6%  
Exports to sales %25.98.3 312.8%   
Imports to sales %0.221.0 0.8%   
Exports (fob) Rs m1,860869 213.9%   
Imports (cif) Rs m122,209 0.6%   
Fx inflow Rs m1,860959 194.0%   
Fx outflow Rs m252,612 1.0%   
Net fx Rs m1,835-1,653 -111.0%   
CASH FLOW
From Operations Rs m1,7191,070 160.6%  
From Investments Rs m-3,148-750 419.9%  
From Financial Activity Rs m1,426-150 -951.9%  
Net Cashflow Rs m-3171 -2.0%  

Share Holding

Indian Promoters % 33.9 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 0.0 18.2 -  
FIIs % 9.9 1.0 990.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 29.1 135.1%  
Shareholders   21,482 28,591 75.1%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   DIVIS LABORATORIES  WOCKHARDT LTD.  VENUS REMEDIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 23, 2017 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - SHASUN PHARMA COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS